1-Alkyl-4-aryl-3,4-dihydro-2(1H)-quinazolinones and thiones. Synthesis and 1H-NMR spectra

DOI: 10.1002/jhet.5570190639

Source and publish data:

Journal of Heterocyclic Chemistry p. 1453 - 1456 (1982)

Update date:2022-07-30

Topics:

Authors:

Houlihan

Cooke Cooke

Danzer Danzer

Nicoletti

Read Full Text PDF DownLoad Join now for total 90,000,000 free articles

Article abstract of DOI:10.1002/jhet.5570190639

Full text of DOI:10.1002/jhet.5570190639

Products guided by the article

Product name:N-TRIFLUOROACETYL-3,4-(METHYLENE-DIOXY)-ANILINE

Cas No:85575-56-0

R&D Labs maybe for 85575-56-0

Shanghai Cheerchem Co., Ltd.

Contact:86-21-50966856

Address:Building 5,300 Chuanzhan Road,Pudong New District,Shanghai
Yingkou Sanzheng Organic Chemical Co. Ltd.

Contact:+86-417-3638818

Address:25 Gengxinli Village, Daqing Road, Yingkou, Liaoning, China
Richest Group Ltd.

Contact:+86 21 5017 5386

Address:No 999,Jiangyue Rd, Minhang Dist ,201114,Shanghai ,China
Hangzhou innopharma technology Co,.Ltd.(expird)

Contact:+86-13388601988

Address:Room845,lixin building, moganshan road, hangzhou, china
Beijing Pure Chem Co.,Ltd.

Contact:+86-10-83993285

Address:Rm.1708, Haobai Tower, Building 6, No.50, North Road, West Third Ring, Haidian District, Beijing, China

Relevant to this article

Doi:10.1021/ja01192a068
(1948)
A one-pot synthetic strategy for construction of the dibenzodiazepine skeleton via a transition metal-free process

Doi:10.1039/c4ob00871e
(2014)
ONE-POT PALLADIUM-CATALYZED SYNTHESIS OF 2,3-DISUBSTITUTED BICYCLO<2.2.1>HEPTANES AND BICYCLO<2.2.1>HEPT-5-ENES

Doi:10.1016/S0040-4039(00)85642-7
(1982)
Conformationally restricted analogues of both (S)-β-homoserine and (S)-aspartic acid from chiral 3-acylamino pyrrolidin-2-ones

Doi:10.1016/j.tet.2005.03.129
(2005)
A re(V)-catalyzed C-N bond-forming route to human lipoxygenase inhibitors

Doi:10.1021/ol050897a
(2005)
Design, synthesis and evaluation of novel cinnamic acid derivatives bearing N-benzyl pyridinium moiety as multifunctional cholinesterase inhibitors for Alzheimer’s disease

Doi:10.1080/14756366.2016.1256883
(2017)

Article Doi